Bumped Kinase Inhibitors, targeting Calcium-dependent Protein Kinase 1 in apicomplexan parasites with a glycine gatekeeper, are promising new therapeutics for apicomplexan diseases. Here we will review advances, as well as challenges and lessons learned regarding efficacy, safety, and pharmacology that have shaped our selection of pre-clinical candidates.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565993 | PMC |
| http://dx.doi.org/10.1016/j.ijpara.2020.01.006 | DOI Listing |
Publication Analysis
Top Keywords
bumped kinase
8
kinase inhibitors
8
lessons learned
8
inhibitors therapy
4
therapy apicomplexan
4
apicomplexan parasitic
4
parasitic diseases
4
diseases lessons
4
learned bumped
4
inhibitors targeting
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!